These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28201528)

  • 1. Pharmacoepidemiology for nephrologists: do proton pump inhibitors cause chronic kidney disease?
    Tomlinson LA; Fogarty DG; Douglas I; Nitsch D
    Nephrol Dial Transplant; 2017 Apr; 32(suppl_2):ii40-ii46. PubMed ID: 28201528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic kidney disease (CKD) patients are exposed to more proton pump inhibitor (PPI)s compared to non-CKD patients.
    Lee HJ; Lee H; Oh SH; Park J; Park S; Jeon JS; Noh H; Han DC; Kwon SH
    PLoS One; 2018; 13(9):e0203878. PubMed ID: 30212538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of proton pump inhibitors and chronic kidney disease: cause or confounding?
    Li T; Xie Y; Al-Aly Z
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):182-187. PubMed ID: 29432214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.
    Klatte DCF; Gasparini A; Xu H; de Deco P; Trevisan M; Johansson ALV; Wettermark B; Ärnlöv J; Janmaat CJ; Lindholm B; Dekker FW; Coresh J; Grams ME; Carrero JJ
    Gastroenterology; 2017 Sep; 153(3):702-710. PubMed ID: 28583827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic use of proton pump inhibitors, adverse events and potential biological mechanisms: A translational analysis.
    Kheloufi F; Frankel D; Kaspi E; Lepelley M; Mallaret M; Boucherie Q; Roll P; Micallef J
    Therapie; 2018; 73(3):273-281. PubMed ID: 29128115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors and chronic kidney disease: is it time to sound the alarm?
    Wyatt CM
    Kidney Int; 2016 Apr; 89(4):732-3. PubMed ID: 26994567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor usage and the associated risk of pneumonia in patients with chronic kidney disease.
    Chen CH; Lin HC; Lin HL; Lin YT; Chou JM; Hsu SP; Fung CP
    J Microbiol Immunol Infect; 2015 Aug; 48(4):390-6. PubMed ID: 24291618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.
    Arora P; Gupta A; Golzy M; Patel N; Carter RL; Jalal K; Lohr JW
    BMC Nephrol; 2016 Aug; 17(1):112. PubMed ID: 27487959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of children and adolescents first prescribed proton pump inhibitors or histamine-2-receptor antagonists: an observational cohort study.
    Ruigómez A; Kool-Houweling LMA; García Rodríguez LA; Penning-van Beest FJA; Herings RMC
    Curr Med Res Opin; 2017 Dec; 33(12):2251-2259. PubMed ID: 28562108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
    Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.
    Barletta JF; Kanji S; MacLaren R; Lat I; Erstad BL;
    J Crit Care; 2014 Dec; 29(6):955-60. PubMed ID: 25081626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
    Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
    Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No Increase in Risk of Acute Myocardial Infarction in Privately Insured Adults Prescribed Proton Pump Inhibitors vs Histamine-2 Receptor Antagonists (2002-2014).
    Landi SN; Sandler RS; Pate V; Lund JL
    Gastroenterology; 2018 Mar; 154(4):861-873.e6. PubMed ID: 29122546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is red meat consumption the confounding factor explaining the association between chronic kidney disease and proton pump inhibitors?
    Desbuissons G; Mercadal L
    Nephrol Ther; 2019 Jul; 15(4):191-192. PubMed ID: 31056405
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them.
    Fu EL; van Diepen M; Xu Y; Trevisan M; Dekker FW; Zoccali C; Jager K; Carrero JJ
    Clin Kidney J; 2021 May; 14(5):1317-1326. PubMed ID: 33959262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
    MacLaren R; Reynolds PM; Allen RR
    JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of chronic kidney disease among users of non-prescribed Chinese herbal medicine in Taiwan.
    Hsieh CF; Huang SL; Chen CL; Chen WT; Chang HC; Wu ML; Yang CC
    Prev Med; 2012 Aug; 55(2):155-9. PubMed ID: 22705017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization and safety of proton-pump inhibitors and histamine-2 receptor antagonists in children and adolescents: an observational cohort study.
    Ruigómez A; Johansson S; Nagy P; García Rodríguez LA
    Curr Med Res Opin; 2017 Dec; 33(12):2201-2209. PubMed ID: 28699796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Proton Pump Inhibitors With Risk of Dementia: A Pharmacoepidemiological Claims Data Analysis.
    Gomm W; von Holt K; Thomé F; Broich K; Maier W; Fink A; Doblhammer G; Haenisch B
    JAMA Neurol; 2016 Apr; 73(4):410-6. PubMed ID: 26882076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of CKD Regression in Patients under Nephrology Care.
    Borrelli S; Leonardis D; Minutolo R; Chiodini P; De Nicola L; Esposito C; Mallamaci F; Zoccali C; Conte G
    PLoS One; 2015; 10(10):e0140138. PubMed ID: 26462071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.